Measuring the Influence of Kefir on Children's Stools on Antibiotics (MILK)

Completed · Not applicable · Has a placebo group

Conditions studied: Respiratory Tract Infections

In brief

The purpose of this study is to determine the effectiveness of commercially available kefir on preventing antibiotic-associated diarrhea compared to placebo in children ages 1-5.

Key facts

Study ID

NCT00481507

Run by

Georgetown University

People needed

125

Starts

2007-07-01

Expected to finish

2008-04-01

Last updated by the study team

2019-07-10

Who can join

Age: 1 and older, up to 5. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Ability to speak and write English
• Aged 1-5 years
• Male or female
• Diagnosed with an upper respiratory infection and placed on a penicillin class antibiotic regimen for 10 days

You may not qualify if…

• Developmental delays
• Chronic conditions, such as diabetes or asthma, that require medication
• Prematurity, birth weight <2500 grams
• Allergy to kefir and/or milk
• Active diarrhea
• Congenital anomalies
• Failure to thrive
• Parental belief of lactose intolerance

Where it is running

• Georgetown University Deptartment of Family Medicine — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.